Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2022-09-14 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document explicitly details a 'Report on transactions of executives and related parties in Coloplast shares and related securities' made according to the Market Abuse Regulation article 19. It lists a specific transaction (exercise of share options) by an executive (Anders Lonning-Skovgaard, CFO). This type of mandatory disclosure regarding personal share transactions by company directors and executives falls directly under the definition of Director's Dealing (DIRS). It is not an Annual Report (10-K), an Earnings Release (ER), or a general regulatory filing (RNS), as it pertains to a very specific insider transaction disclosure.
2022-09-14 English
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document is titled "Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer" (Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in respect of transactions relating to the issuer’s securities). It explicitly references compliance with the Market Abuse Regulation (MAR) Article 19 and details a transaction (exercise of stock options) by an Executive Vice President/CFO. This structure and content precisely match the definition of Director's Dealing reports, which track insider transactions.
2022-09-14 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' translates to 'Transactions by board members, executives or closely related persons with Coloplast shares'. This is a standard notification for insider trading, which falls under the 'Director's Dealing' category. The document is short and points to an attached PDF, confirming it is the official notification of these transactions.
2022-09-14 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a short announcement regarding 'Trading in Coloplast shares by board members, executives or associated persons'. It explicitly directs the reader to an enclosed PDF attachment for the details of the transaction. According to the 'Menu vs Meal' rule, since this is a short announcement (587 characters) notifying the reader of an attached report rather than the report itself, it is classified as a Director's Dealing notification.
2022-09-14 Danish
Approval of prospectus for COLOPLAST A/S; Debt securities ≥ EUR 100.000
Capital/Financing Update Classification · 1% confidence The document is a 'Base Prospectus' for a Euro Medium Term Note Programme issued by Coloplast Finance B.V. and Coloplast A/S. It outlines the terms, conditions, and legal framework for future debt issuance. According to the filing definitions, documents related to fundraising, financing activities, or capital structure changes are classified as 'CAP'. While it is a prospectus, it functions as a capital/financing update document within the provided taxonomy.
2022-05-16 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 1% confidence The document is titled 'Selskabsmeddelelse nr. 06/2022 - Coloplast offentliggør obligationsudstedelse på EUR 2,2 mia. som led i selskabets Euro Medium Term Note-program' (Company announcement no. 06/2022 - Coloplast announces bond issuance of EUR 2.2 billion as part of the company's Euro Medium Term Note program). The content details the issuance of senior bonds totaling EUR 2.2 billion, including tranche sizes, maturity dates, coupon rates, and intended use of proceeds (refinancing a loan for an acquisition). This clearly describes a financing activity, specifically debt issuance. This aligns directly with the definition for Capital/Financing Update (CAP). Although it is a formal announcement, the core subject matter is the financing event itself, not just the announcement of a report.
2022-05-11 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.